Health Care: Health Services

WuXi PharmaTech (Cayman) Inc. (WX: NYSE)

$20.63 -0.26 | -1.24%
05/23/13 - 10:44 AM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 499.91M 407.18M 334.06M 270.02M
Cost of Sales 275.00M 216.74M 177.26M 137.64M
Gross Operating Profit 224.91M 190.44M 156.80M 132.38M
Selling, General, and Administrative Expenses 85.66M 72.63M 56.09M 56.28M
Research & Development 8.14M 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 131.12M 117.81M 100.71M 76.10M
Depreciation & Amortization 41.67M 34.00M 29.21M 23.97M
Interest Income 7.73M 6.06M 1.58M 1.12M
Other Income - Net 11.94M 8.51M 28.41M 6.78M
Special Income / Charges -3.42M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 105.70M 98.38M 101.49M 60.03M
Interest Expense 1.72M 790.00K 436.00K 1.07M
Pre-Tax Income 103.98M 97.58M 101.06M 58.96M
Income Taxes 17.39M 16.61M 10.24M 5.53M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 86.58M 80.98M 90.81M 53.43M
Net Income From Discontinued Operations 0.00 0.00 0.00 -558.00K
Net Income From Total Operations 86.58M 80.98M 90.81M 52.87M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 86.58M 80.98M 90.81M 52.87M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 90.00M 80.98M 90.81M 53.43M
Preferred Dividends
Net Income Available To Common 86.58M 80.98M 90.81M 53.43M
Basic EPS from Continuing Ops. 1.20 1.12 1.28 0.80
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.20 1.12 1.28 0.80
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.20 1.12 1.28 0.80
Basic Normalized Net Income/Share 1.25 1.12 1.28 0.80
EPS fr Continuing Ops. 1.20 1.04 1.20 0.72
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.20 1.04 1.20 0.72
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.20 1.04 1.20 0.72
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 1.25 1.04 1.20 0.72
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with WX

View All

Latest WX Headlines from TheStreet

More Financial News for WX

Press Releases for WX

See All Press Releases

Partner Headlines for WX

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter